Patents
Sitemap › A61 - Medical or veterinary science; Hygiene › A61K - Preparations for medical, dental, or toilet purposes › A61K 31 - Medicinal preparations containing organic active ingredients
Patents for A61K 31 - Medicinal preparations containing organic active ingredients (785,912)
05/1999
05/27/1999WO1999025352A1 Combination therapy for the treatment of aids
05/27/1999WO1999025351A1 Antimalaria pharmaceutical compositions
05/27/1999WO1999025350A1 Treatment of diabetic retinopathy
05/27/1999WO1999025349A1 Anaesthetic formulation
05/27/1999WO1999025348A1 5-ht1f agonists
05/27/1999WO1999025347A2 Chemical compounds having ion channel blocking activity for the treatment of immune dysfunction
05/27/1999WO1999025346A1 Novel apoptosis inhibitors
05/27/1999WO1999025344A1 Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
05/27/1999WO1999025343A1 Granules comprising clavulanate and one or more excipients
05/27/1999WO1999025341A1 Use of histamine for elevating blood histamine levels
05/27/1999WO1999025340A1 Treatment for alzheimer's disease
05/27/1999WO1999025339A1 Treatment for alzheimer's disease
05/27/1999WO1999025338A1 Pharmaceutical composition containing zafirlukast
05/27/1999WO1999025337A1 Composition of ingredients for a beverage having a delayed aversion effect
05/27/1999WO1999025336A1 Methods for preventing restenosis using tocotrienols
05/27/1999WO1999025333A1 USE OF Δ5-ANDROSTENE-3β-OL-7,17-DIONE IN THE TREATMENT OF LUPUS ERYTHEMATOSUS
05/27/1999WO1999025332A1 Composition with azelaic acid
05/27/1999WO1999025330A1 Treatment of scar tissue using lipoic acid
05/27/1999WO1999025329A1 Use of sulphinyl benzhydryl derivatives for treating drug-induced sleepiness
05/27/1999WO1999025328A1 (+)-ephedrine as a sympathomimetic drug
05/27/1999WO1999025327A2 Small molecule intervention in hiv-1 replication
05/27/1999WO1999025323A1 Omeprazole formulation
05/27/1999WO1999025321A1 High drug load immediate and modified release oral dosage formulations and processes for their manufacture
05/27/1999WO1999025270A2 OCULAR THERAPYY IN KERATOCONJUNCTIVITIS SICCA USING TOPICALLY APPLIED ANDROGENS OR TGF-$g(b)
05/27/1999WO1999025192A1 USE OF Δ5-ANDROSTENE-3β-OL-7,17-DIONE IN THE TREATMENT OF ARTHRITIS
05/27/1999WO1999025190A1 Surfactant-based antimicrobial compositions and methods for using same
05/27/1999WO1999018952B1 UPREGULATION OF TYPE III ENDOTHELIAL CELL NITRIC OXIDE SYNTHASE BY HMG-CoA REDUCTASE INHIBITORS
05/27/1999WO1999018099B1 Aryl thiophene derivatives as pde iv inhibitors
05/27/1999WO1999014346A3 SENSE mRNA THERAPY
05/27/1999WO1999013875A8 Use of nitroxides for the treatment of essential hypertension
05/27/1999WO1999012933A3 Pyrrolopyrrolone derivatives as inhibitors of neutrophil elastase
05/27/1999WO1999012535A8 Use of sulphonamide benzene derivatives to obtain a medicine for treating retrograde ejaculation or aspermia
05/27/1999WO1999012529A3 Transdermal therapeutic system comprising a reservoir-type pressure-sensitive adhesive layer and a back layer with uni-directional resilience
05/27/1999WO1999010480A3 New tissue-specific calpaines, their production and their use
05/27/1999WO1999010004A3 Regulation of muscle tissues by hedgehog-like polypeptides, and formulations and uses related thereto
05/27/1999WO1999003817A3 Aliphatic propargylamines as cellular rescue agents
05/27/1999WO1998055495A3 Immunostimulatory oligonucleotides, compositions thereof and methods of use thereof
05/27/1999WO1998049292A3 Polypeptides associated with activator receptors and their biological applications
05/27/1999DE19751949A1 Neuronal regeneration and neurodegenerative disease treatment with aminomethyl-chroman derivatives
05/27/1999DE19751948A1 Rapid preparation of 8-alkoxy-quinolone-carboxylic acid derivative antibacterial agent, e.g. gatifloxacin, in high purity
05/27/1999DE19750702A1 Antisense oligonucleotides that bind to sequences encoding human tenascin for treating depigmentation, cancer, inflammation and cardiovascular disease
05/27/1999DE19750453A1 Preparation of hypocholesterinemic agents
05/27/1999CA2628019A1 Chemical synthesis of 6-o-alkyl erythromycin a
05/27/1999CA2311471A1 Use of .delta.5-androstene-3.beta.-ol-7,17-dione in the treatment of arthritis
05/27/1999CA2310632A1 Use of .delta.5-androstene-3.beta.-ol-7,17-dione in the treatment of lupus erythematosus
05/27/1999CA2310630A1 Cyclopentane heptan(ene)oic acid, 2-heteroarylalkenyl derivatives as therapeutic agents
05/27/1999CA2310563A1 Vector for tissue-specific replication and gene expression
05/27/1999CA2310410A1 Salts of 5,5'-arylidenebisbarbituric and 5,5'-arylidenebis(2-thiobarbituric) acids and 5,5'-arylidenebis(2-thiobarbituric) acids having an antibacterial, anti-chlamydial, antiviral and immuno-modulating activity
05/27/1999CA2310332A1 Recovery of taxanes from plant material
05/27/1999CA2310319A1 2-pyrrolidinone derivatives substituted at position 4 for reducing the extracellular glutamate level
05/27/1999CA2310255A1 Use of histamine for elevating blood histamine levels
05/27/1999CA2310250A1 Treatment for alzheimer's disease
05/27/1999CA2310249A1 Treatment for alzheimer's disease
05/27/1999CA2310248A1 5-ht1f agonists
05/27/1999CA2310244A1 Pyranones, methods of preparing and using them
05/27/1999CA2310233A1 Advanced glycation end-product intermediaries and post-amadori inhibition
05/27/1999CA2310232A1 Methods for preventing restenosis using tocotrienols
05/27/1999CA2310026A1 Hypocholesteremic preperations containing mixtures of phytostenol(ester)s and conjugated fatty acids, and methods of reducing serum cholesterol levels using the same
05/27/1999CA2309966A1 Combination of active principles, in particular of tetrahydropyridins and acetylcholinesterase inhibiting agents, for treating senile dementia such as alzheimer dementia
05/27/1999CA2309905A1 Isoquinoline derivatives and their therapeutical use
05/27/1999CA2309859A1 2-arylbenzo¬b|thiophenes useful for the treatment of estrogen deprivation syndrome
05/27/1999CA2309829A1 Preparation of terazosin hydrochloride dihydrate
05/27/1999CA2309826A1 Alphavirus vectors for paramyxovirus vaccines
05/27/1999CA2309824A1 2-aryl-3-aroylbenzo¬b|thiophenes useful for the treatment of estrogen deprivation syndrome
05/27/1999CA2309745A1 Progestogen-antiprogestogen regimens
05/27/1999CA2309744A1 Use of mirtazapine for treating sleep apneas
05/27/1999CA2309392A1 Method for treating attention deficit disorder
05/27/1999CA2309390A1 Cdk2 protein and cdk2 protein complexes
05/27/1999CA2309325A1 Hypocholesteraemic preparations containing phytostenolesters of conjugated fatty acids, and methods of reducing serum cholesterol levels using the same
05/27/1999CA2309242A1 Novel 19-nor steroids substituted in position 11.beta., preparation method and intermediates, application as medicines and pharmaceutical compositions containing them
05/27/1999CA2309164A1 Combination therapy for the treatment of aids
05/27/1999CA2308746A1 Novel heterocyclically substituted .alpha.-hydroxycarboxylic acid derivatives, method for producing the same and their use as endothelin receptor_antagonists
05/27/1999CA2306460A1 Aromatic sulfone hydroxamic acid metalloprotease inhibitor
05/27/1999CA2303961A1 Use of oxazolidinone derivatives for treating psoriasis, arthritis and reducing the toxicity of cancer chemotherapy
05/27/1999CA2276753A1 New process
05/27/1999CA2272402A1 Granules comprising clavulanate and one or more excipients
05/26/1999EP0918059A1 Substituted imidazoline derivatives, their preparation, their use, and pharmaceutical compositions containing them
05/26/1999EP0917875A1 Aqueous eye drops containing apafant as principal agent
05/26/1999EP0917874A1 Process for the long term reduction of body fat stores, insulin resistance, hyperinsulinemia and hypoglycemia in vertebrates
05/26/1999EP0917873A1 Eyedrops
05/26/1999EP0917871A2 Cosmetic and pharmaceutical compositions comprising ascorbic acid derivatives
05/26/1999EP0917826A1 Aminoacid formulations for third age persons and process for calculating such formulations
05/26/1999EP0917591A1 23s rna nucleotide fragment of the clhamydia genus bacteria, uses as probe, primer, and in a reagent and a detection and a detection method
05/26/1999EP0917588A1 Method for preparing a polydispersed saccharide composition and resulting polydispersed saccharide composition
05/26/1999EP0917587A1 A new method for producing pravastatin precursor, ml-236b
05/26/1999EP0917572A2 Secreted proteins and polynucleotides encoding them
05/26/1999EP0917569A2 Antitumor antisense sequences directed against r1 and r2 components of ribonucleotide reductase
05/26/1999EP0917539A1 Anticoagulant peptide fragments derived from apolipoprotein b-100
05/26/1999EP0917538A1 Eukaryotic cells expressing at their surface at least an hla-g isoform and their applications
05/26/1999EP0917534A2 6,7-oxygenated steroids and uses related thereto
05/26/1999EP0917530A1 Tetrahydroisoquinoline derivatives as modulators of dopamine d3 receptors
05/26/1999EP0917528A1 New amidino derivatives and their use as thrombin inhibitors
05/26/1999EP0917473A1 Covalent polar lipid conjugates with biologically-active compounds for use in salves
05/26/1999EP0917472A1 Antiprotozoal composition
05/26/1999EP0917469A1 Methods for inducing bone formation
05/26/1999EP0917466A1 Oral contraceptive
05/26/1999EP0917465A1 Antimalarial and anti-babesiosis agents and pharmaceutical compositions containing same
05/26/1999EP0917464A1 Use of amines to produce drugs for preventing tumour cell proliferation
05/26/1999EP0917463A2 Tramadol multiple unit formulations
05/26/1999EP0917462A1 Cell adhesion inhibitors
1 ... 6495 6496 6497 6498 6499 6500 6501 6502 6503 6504 6505 6506 6507 6508 6509 6510 6511 6512 6513 6514 6515 ... 7860